Today, muscle atrophy is often unavoidable when you can't move due to severe injury, old age or diseases like amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). However, Harvard ...

Amyotrophic Lateral Sclerosis or ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. ALS typically causes muscle atrophy, difficulty in breathing and ...

Nicholas R. Metrus, MD, is a neurologist and neuro-oncologist with Atlantic Health System. He has completed research on complications of cancer and primary brain tumors like hypermutator gliomas that ...

Just 3 disease-modifying treatments—edaravone, riluzole, and sodium phenylbutyrate and taurursodiol (PB/TURSO)—are currently FDA approved to slow progression of amyotrophic lateral sclerosis (ALS). A ...

Amyotrophic lateral sclerosis (ALS) is a condition that causes the degeneration of the nerve cells in the nervous system, affecting certain neurons in the spinal cord. ALS is a fatal disease that ...

Amyotrophic lateral sclerosis (ALS) cannot spread through contact or proximity, so it is not contagious. Most cases of ALS occur without a known trigger or reason, although some cases occur due to ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...

The technology was licensed on an exclusive worldwide basis from the Universitat Autonomo de Barcelona in Barcelona, Spain. ANEW's lead gene therapy candidate utilizes a muscle-targeting AAV9 viral ...

A substantial number of drugs found to alleviate symptoms of motor neuron diseases (MNDs) in animal models have failed in clinical trials. While the reasons for this are not clear, modeling with ...

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, has become an important health issue affecting the elderly. Researchers have ...